ストックスクリーナーアプリを入手
101.83
2.68%
-2.805
プレマーケット:
101.04
-0.795
-0.78%
Blueprint Medicines Corp (BPMC) 最新ニュース
Blueprint Medicines (NASDAQ:BPMC) Upgraded at StockNews.com - Defense World
Blueprint Medicines’ (BPMC) Buy Rating Reiterated at HC Wainwright - Defense World
Blueprint Medicines First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Blueprint Medicines Corporation (NASDAQ:BPMC) Q1 2025 Earnings Call Transcript - Insider Monkey
Blueprint Medicines Corp (BPMC) Stock: A Year of Highs and Lows in the Market - investchronicle.com
BPMC: HC Wainwright & Co. Reiterates Buy Rating on Blueprint Med - GuruFocus
Blueprint Medicines Corp (BPMC) Performance and Fundamentals Dashboard tells a completely different story - Sete News
BPMC: HC Wainwright & Co. Reiterates Buy Rating on Blueprint Medicines | BPMC Stock News - GuruFocus
Blueprint Medicines Corp (BPMC) Q1 2025 Earnings Call Highlights: Strong AYVAKIT Revenue Growth ... - Yahoo Finance
Blueprint Medicines reports Q1 EPS 1c, consensus (44c) - TipRanks
Blueprint Medicines Reports Strong Q1 2025 Growth - TipRanks
Earnings call transcript: Blueprint Medicines Q1 2025 beats EPS, stock rises - Investing.com India
Blueprint Medicines Corp. Reports Strong Earnings Growth - TipRanks
Blueprint Medicines (BPMC) Faces Q1 Revenue Miss, Focuses on Str - GuruFocus
Blueprint Medicines Corp Reports Q1 2025 Earnings: EPS of -$0.56 - GuruFocus
Blueprint Medicines Corp (NASDAQ: BPMC) Stock Jumping 14.80% Over A Month – Any Room For Its Value To Rise? - Marketing Sentinel
Predicting Blueprint Medicines Corp’s (BPMC) earnings for the current quarter - uspostnews.com
Blueprint Medicines Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Blueprint Medicines Q1 2025 slides: AYVAKIT revenue surges 61%, guidance raised - Investing.com India
Blueprint Medicines: Q1 Earnings Snapshot - marketscreener.com
Blueprint Medicines Corp earnings beat by $0.50, revenue fell short of estimates - Investing.com
Blueprint Medicines Reports First Quarter 2025 Results - TradingView
Blueprint Medicines Reports First Quarter 2025 Results and Raises AYVAKIT®/AYVAKYT® (avapritinib) Full Year Revenue Guidance - PR Newswire
Blueprint Medicines patents new EGFR mutant inhibitors for NSCLC - BioWorld MedTech
Blueprint Medicines (NASDAQ:BPMC) Price Target Cut to $130.00 by Analysts at Needham & Company LLC - Defense World
Needham Adjusts Price Target for Blueprint Medicines (BPMC) Ahea - GuruFocus
What Analysts Are Saying About Blueprint Medicines Stock - Benzinga
Blueprint Medicines stock target cut to $130 at Needham - Investing.com
Press Release Distribution & PR Platform - ACCESS Newswire
Envestnet Asset Management Inc. Buys 3,723 Shares of Blueprint Medicines Co. (NASDAQ:BPMC) - Defense World
Blueprint Medicines Announces Q1 2025 Earnings Date: Key Biotech Updates Coming May 1 - Stock Titan
Blueprint Medicines Corp (BPMC) is looking forward to a strong quarter - Sete News
Blueprint Medicines (BPMC) Expected to Beat Earnings Estimates: Should You Buy? - Yahoo Finance
Blueprint Medicines (BPMC) to Release Earnings on Thursday - Defense World
Blueprint Medicines Corporation (BPMC): Among Takeover Rumors Hedge Funds Are Buying - Insider Monkey
Wells Fargo & Company MN Cuts Stock Holdings in Blueprint Medicines Co. (NASDAQ:BPMC) - Defense World
Blueprint Medicines Co. (NASDAQ:BPMC) Shares Sold by LPL Financial LLC - Defense World
BPMC stock rated an Equal-weight by Morgan Stanley - knoxdaily.com
Wedbush Decreases Earnings Estimates for Blueprint Medicines - Defense World
What is Wedbush’s Forecast for BPMC Q3 Earnings? - Defense World
Wedbush Reaffirms “Outperform” Rating for Blueprint Medicines (NASDAQ:BPMC) - Defense World
Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT) and Blueprint Medicines (BPMC) - The Globe and Mail
Blueprint Medicines Co. (NASDAQ:BPMC) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
Franklin Resources Inc. Lowers Stake in Blueprint Medicines Co. (NASDAQ:BPMC) - Defense World
O Shaughnessy Asset Management LLC Reduces Stock Position in Blueprint Medicines Co. (NASDAQ:BPMC) - Defense World
Blueprint Medicines Corp (BPMC) Shares Plummet Below 1-Year High - News Heater
Blueprint Medicines’ (BPMC) “Buy” Rating Reaffirmed at Needham & Company LLC - Defense World
Breaking Down Blueprint Medicines: 14 Analysts Share Their Views - Benzinga
Blueprint Medicines at Needham Conference: Strategic Growth in Mastocytosis - Investing.com
Blueprint Medicines Corp [BPMC] stock was sold by Haviland Kate at the price of US$0.22 million - knoxdaily.com
Blueprint Medicines stock hits 52-week low at $80.64 - Investing.com
0.39%
3.66%
大文字化:
|
ボリューム (24 時間):